Oak Street Health and Interwell Health announced the launch of OakWell, a joint venture that will offer the highest-quality primary care to end-stage kidney disease, ESKD, patients directly in the dialysis center. "There is a significant opportunity to leverage the time spent by dialysis patients in-center to improve their overall quality of life," said Dr. David Buchanan, Chief Clinical Officer at Oak Street Health. "Receiving personalized, preventive primary care from expert care teams can positively impact patient health. We are thrilled to launch this innovative joint venture to remove barriers to comprehensive care for people living with kidney failure." OakWell will initially begin offering care services in Chicago, Houston and Dallas-Fort Worth dialysis centers in Q3 of 2023.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH:
- Oak Street Health downgraded to Peer Perform from Outperform at Wolfe Research
- Oak Street Health downgraded to Market Perform from Outperform at TD Cowen
- Oak Street Health reports FY22 revenue $2.16B, consensus $2.15B
- Oak Street Health downgraded to Neutral from Overweight at JPMorgan
- Oak Street Health downgraded to Market Perform from Outperform at Bernstein